Vapotherm - Gilde Healthcare



Exeter (NH), USA

Oxygen therapy
Since: 2014
Exit: 2018

US-based MedTech company commercializing oxygen therapy for patients in respiratory distress.

Vapotherm is a worldwide, commercial company that develops, manufactures and sells Precision Flow, a high-velocity oxygen therapy for patients in respiratory distress. By conditioning the oxygen to make it tolerable for patients of all ages, Precision Flow, allows patients to comfortably eat, speak and sleep while receiving a high level of respiratory support. Such support has been shown to help patients avoid expensive and invasive care (such as intubation) and reduce their length of stay within a hospital. The essence of better care at lower cost.

Vapotherm is based in Exeter, New Hampshire.

Vapotherm is now publicly listed on the NYSE under the ticker symbol VAPO.

More Vapotherm news

Vapotherm raises $87 million via public offering

Respiratory company Vapotherm provides business update in response to COVID-19 pandemic

Vapotherm raises $56M via an IPO at NYSE

Vapotherm Inc. Announces $30 Million Financing Round

Vapotherm Inc Closes $20 Million Series C Financing Round

Gilde Healthcare leads $24 million financing round of respiratory care provider Vapotherm